Radiological Versus Clinical 1-Year Outcomes of Dupilumab in Refractory CRSwNP: A Real-Life Study.

Francesco Giombi Gian Marco PaceEmanuele NappiGianmarco GiuntaGiovanna MuciFrancesca PirolaFabio FerreliEnrico HefflerGiovanni PaolettiCaterina GiannittoGiuseppe MercanteMarco FranconeGiuseppe SprianoGiorgio Walter CanonicaLuca Malvezzi

Published in: The Laryngoscope (2023)

Level 4. According to the Oxford Center for Evidence-Based Medicine 2011 level of evidence guidelines, this non-randomized retrospective cohort study is classified as level 4 evidence Laryngoscope, 2023.

Keyphrases

open label
clinical trial
atopic dermatitis
phase iii
placebo controlled
insulin resistance